-
公开(公告)号：MY162396A
公开(公告)日：2017-06-15
申请号：MYPI2013000767
申请日：2011-09-02
Applicant: UCB PHARMA SA
Inventor： PARTON ANDREW HARRY , ALI MEZHER HUSSEIN , BROOKINGS DNIEL CHRISTOPHER , BROWN JULIEN ALISTAR , FORD DANIEL JAMES , FRANKLIN RICHARD JEREMY , LANGHAM BARRY JOHN , NEUSS JUDI CHARLOTTE , QUINCEY JOANNA RACHEL
IPC: C07D471/04 , A61K31/519 , A61P9/00 , A61P25/28 , A61P29/00
Abstract: A SERIES OF QUINOLONE AND QUINOXALINE DERIVATIVES COMPRISING A FLUORINATED ETHYL SIDE-CHAIN, BEING SELECTIVE INHIBITORS OF PI3 KINASE ENZYMES, ARE ACCORDINGLY OF BENEFIT IN MEDICINE, FOR EXAMPLE IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE, CARDIOVASCULAR, NEURODEGENERATIVE, METABOLIC, ONCOLOGICAL, NOCICEPTIVE OR OPHTHALMIC CONDITIONS.
-
公开(公告)号：BR112014011404A2
公开(公告)日：2017-05-30
申请号：BR112014011404
申请日：2012-11-09
Applicant: UCB PHARMA SA
Inventor： PALLAVI BHATTA , RALPH ADAMS , SAM PHILLIP HEYWOOD
Abstract: 1/1 resumo "moléculas de anticorpos com especificidade para o ox40 humano" a invenção refere-se a moléculas de anticorpos possuindo especificidade para determinantes antigênicos do ox40 humano, utilizações terapêuticas das moléculas de anticorpos e métodos de produção de tais moléculas de anticorpos.
-
123.发明专利
公开(公告)号：IL224841A
公开(公告)日：2017-03-30
申请号：IL22484113
申请日：2013-02-21
Applicant: UCB PHARMA SA
IPC: A61K31/519 , A61P35/00 , A61P43/00
Abstract: Disclosed are a series of quinoline and quinoxaline derivatives comprising a fluorinated ethyl side-chain, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. The compounds are of general formula (I):
-
公开(公告)号：PL2527371T3
公开(公告)日：2017-02-28
申请号：PL12174216
申请日：2008-09-04
Applicant: UCB PHARMA SA
Inventor： MARSHALL DIANE , SHAW STEVAN GRAHAM
-
-
Patent Agency Ranking
公开(公告)号：BR112013032871A2
公开(公告)日：2017-01-24
申请号：BR112013032871
申请日：2012-07-13
Applicant: UCB PHARMA SA
Inventor： HUMPHREYS DAVID PAUL , ELLIS MARK
Abstract: 1/1 resumo “cepa hospedeira bacteriana que expressa dsbc recombinante” a presente invenção fornece uma célula bacteriana gram-negativa recombinante que compreende um vetor de expressão que compreende um polinucleotídeo recombinante que codifica dsbc e um ou mais polinucleotídeos que codificam um anticorpo ou um fragmento de ligação de antígeno deste que liga-se especificamente a cd154.
-
公开(公告)号：IL206902A
公开(公告)日：2016-11-30
申请号：IL20690210
申请日：2010-07-08
Applicant: UCB PHARMA SA
IPC: A61M20060101
Abstract: The syringe systems disclosed herein provide in part devices for allowing patients with compromised joint strength to more easily administer medicine. Certain exemplary syringe embodiments include a handle forming a handgrip, a syringe barrel that magnifies the dosage marks located on an inner barrel, and a tip cap slidably engageable with the syringe barrel for shielding a needle.
-
128.发明专利
公开(公告)号：LT2308975T
公开(公告)日：2016-11-10
申请号：LT10010795
申请日：2001-06-05
Applicant: UCB PHARMA SA
-
公开(公告)号：AU2011206586B2
公开(公告)日：2016-10-27
申请号：AU2011206586
申请日：2011-01-13
Applicant: UCB PHARMA SA
Inventor： ELLIS MARK , HUMPHREYS DAVID PAUL
Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising a mutant spr gene encoding a mutant spr protein and wherein the cell comprises a non-recombinant wild-type chromosomal Tsp gene.
-
公开(公告)号：DK2527371T3
公开(公告)日：2016-10-24
申请号：DK12174216
申请日：2008-09-04
Applicant: UCB PHARMA SA
Inventor： MARSHALL DIANE , SHAW STEVAN GRAHAM
-
-
-
-
-
-
-
-
-
Search Results
1465
records
(took 0.026 seconds)
